Wednesday, 16 November 2022

ONGLYZA LAWSUIT

ONGLYZA LAWSUIT Onglyza (saxagliptin) and Kombiglyze XR (saxagliptin and metformin) belong to a new class of diabetic drugs known as DPP-4 inhibitors. Onglyza gained federal drug approval by the U.S. Food & Drug Administration (FDA) despite initial concerns over the cardiovascular safety of the drug. These concerns were echoed in a post-marketing safety study that found Onglyza may be associated with an increased risk of heart failure and an increased risk of death. If you or a loved one took Onglyza as directed and suffered from Onglyza side effects including heart failure or other cardiovascular injuries—such as congestive heart failure or myocardial infarction, after starting Onglyza therapy, contact Onglyza lawyer Timothy L. Miles today to see if you are eligible for a Onglyza lawsuit and possibly entitled to substantial compensation. https://www.classactionlawyertn.com/onglyza.html Follow us: https://www.facebook.com/timmileslaw https://twitter.com/TimMile83043830 https://www.linkedin.com/company/the-law-offices-of-timothy-l-miles https://www.youtube.com/channel/UCbEh7RkQ94C6KVlZGubIYmQ https://www.pinterest.com/tmiles676767/ https://www.instagram.com/10k_law/1

from
https://www.youtube.com/watch?v=PXIpHEy15PY

Sunday, 13 November 2022

TASIGNA LAWSUIT

TASIGNA LAWSUIT ​First approved in 2007, Tasigna (nilotinib), is a prescription medication used to treat chronic myeloid leukaemia (CML). Tasigna is part of a class of drugs known as tyrosine kinase inhibitors (TKIs). Other TKI drugs include Gleevec (imatinib), also made by Novartis, and Sprycel (dasatinib), made by Bristol-Myers Squibb. ​ These drugs help treat leukemia by blocking the protein tyrosine kinases—a protein that stimulates the growth of cancer cells. In blocking this protein, TKI drugs like Tasigna help stop leukemia from spreading. Tasigna is prescribed as a twice daily drug and is taken orally in capsule form. Injured patients and their families are now filing lawsuits against Tasigna manufacturer Novartis, on the grounds that the company failed to warn of the drug’s cardiovascular risks. Studies have allegedly linked the drug to serious cardiovascular side effects like Long QT syndrome, a condition involving irregular heartbeats, and atherosclerosis, a disease that causes plaque to build up in the arteries.​​ If you or a loved one took Tasigna and suffered heart or circulation problems (including complications like blocked arteries, heart attacks, or strokes), you could be eligible for a Tasigna Lawsuit. If you suffered Tasigna side effects, including Tasigha cardiovascular side effects, call Tasigna lawyer Timothy L. Miles today for a free case evaluation and see if you qualify for a Tasigna lawsuit. Follow us: https://www.facebook.com/timmileslaw https://twitter.com/TimMile83043830 https://www.linkedin.com/company/the-law-offices-of-timothy-l-miles https://www.youtube.com/channel/UCbEh7RkQ94C6KVlZGubIYmQ https://www.pinterest.com/tmiles676767/ https://www.instagram.com/10k_law/1

from
https://www.youtube.com/watch?v=FGDpHb8l4A8

VICTOZA CANCER LAWSUIT

VICTOZA CANCER LAWSUIT ​Hundreds of Victoza cancer lawsuits filed by victims from across the country allege that Victoza, which is an incretin mimetic drug used to treat type 2 diabetes, may cause pancreatic cancer and that the manufacturer of Victoza, Novo Nordisk, failed to warn them of this risk. ​ Other incretin mimetic drugs have also been linked to this dangerous side effect. As a result, Januvia, Janumet, and Byetta have also been linked to pancreatic cancer. Manufacturers Novo Nordisk, Merck & Co., Eli Lilly, and Amylin Pharmaceuticals now hundreds of lawsuits that have been coordinated for pretrial proceedings in a multidistrict litigation (MDL) in Southern California while further research continues on the question of does Victoza cause pancreatic cancer continues. ​ If you or a loved one took Victoza were later diagnosed with pancreatic cancer, contact Victoza Cancer Lawyer Timothy L. Miles today and see if you are eligible for a Victoza cancer lawsuit and may be entitled to substantiate compensation. https://www.classactionlawyertn.com/victoza.html Follow us: https://www.facebook.com/timmileslaw https://twitter.com/TimMile83043830 https://www.linkedin.com/company/the-law-offices-of-timothy-l-miles https://www.youtube.com/channel/UCbEh7RkQ94C6KVlZGubIYmQ https://www.pinterest.com/tmiles676767/ https://www.instagram.com/10k_law/1

from
https://www.youtube.com/watch?v=F6V6QQVjSoA

Friday, 4 November 2022

JUUL ADDICTION LAWSUIT

JUUL ADDICTION LAWSUIT

from
https://www.youtube.com/watch?v=hDwYmVVvxJE

JUUL ADDICTION LAWSUIT | JULE LAWSUIT LAWYER |

JUUL ADDICTION LAWSUIT The Juul e-cigarette came on the market in 2015. Introduced by Juul Labs, Inc. (JUUL Labs) as a safer alternative than smoking traditional cigarettes, Juul quickly became the dominant player in the vaping industry, accounting for approximately 75% of all e-cigarettes sold. But, as health concerns over vaping continued to rise, and in particular serious health consequences caused by vaping Juul, the U.S. Food and Drug Administration (FDA) ordered Juul Labs to cease selling its vaping products in 2002. However, the FDA place a temporary hold on enforcing its prior order in July 2002. The FDA’s action came after a study and subsequent article published in June 2022 which found a surge in the sale of Juul products was associated with a sharp rise in daily vaping and tobacco use among youth. To date, there have been nearly 4,000 Juul Addiction Lawsuits filed alleging Juul Labs failing to warn about the risk of the Juul e-cigarette and engaging in deceptive advertising. If you or a loved one have become addicted to nicotine by using Juul devices while under the age of 18 and before November of 2018, contact Juul lawsuit lawyer Timothy L. Miles today as you could be eligible to file a Juul lawsuit and possibly be entitled to significant compensation. https://www.classactionlawyertn.com/juul-addiction-lawsuit.html #juul #vaping #minor

from
https://www.youtube.com/watch?v=_-8rz6hIty8

AUTODESK CLASS ACTION LAWSUIT

The Autodesk class action lawsuit seeks to represent purchasers or acquirers of Autodesk, Inc. (NASDAQ: ADSK) publicly traded securities bet...